Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia
A Randomized-controlled Clinical Trial to Treat Chinese Advanced AGA With Umbilical Cord-derived Mesenchymal Stem Cell Exosomes
1 other identifier
interventional
50
1 country
1
Brief Summary
A total of 50 patients with androgenetic alopecia were selected for the study. Patients who met the inclusion/exclusion criteria were randomly assigned to groups A and B in a 1:1 ratio to receive treatment, with the enrollment date designated as Day 1. Group A visited the clinic once each in the first, second, and third months for treatment with exosomes, while Group B visited the clinic twice each in the first, second, and third months for treatment with exosomes. At the time points of 1, 2, 3, and 6 months after the start of the treatment period, dermatoscopic examinations were conducted on patients in both groups. The differences in hair growth density, hair shaft thickness, and follicle counts within a 1 cm diameter area were compared between the two groups. Additionally, the data differences for each subject at baseline and at the end of the experiment were also assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2024
CompletedFirst Submitted
Initial submission to the registry
November 17, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2024
CompletedNovember 20, 2024
November 1, 2024
3 months
November 17, 2024
November 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
hair diameters changed over time
hair diameters changed over time
0 days, 1 month, 3 months, 6 months
Study Arms (2)
Group A
EXPERIMENTALGroup A visited the clinic once each in the first, second, and third months for treatment with exosomes
Group B
EXPERIMENTALGroup B visited the clinic twice each in the first, second, and third months for treatment with exosomes.
Interventions
Human umbilical cord mesenchymal stem cells
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Plastic and Aesthetic Surgery, Nanfang Hospital Southern 8 Medical University
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2024
First Posted
November 20, 2024
Study Start
June 28, 2024
Primary Completion
September 28, 2024
Study Completion
December 28, 2024
Last Updated
November 20, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share